News Articles on {?keyword?} | ABS-CBN News

Protein on infected cells protects coronavirus from immune system

Nancy Lapid, Reuters
Posted at Sep 28 07:11 AM

A protein called CD47 that helps damaged cells avoid destruction by the immune system may be contributing to severe cases of COVID-19. Read more »

India bans export of Covid-19 treatment drug remdesivir

Agence France-Presse
Posted at Apr 12 06:31 AM

NEW DELHI - India on Sunday banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with increasing demand for the coronavirus treatment drug. Read more »

WHO: Nations mulling Gilead's COVID drug should consider trial flop, too

Stephanie Nebehay and John Miller, Reuters
Posted at Oct 24 04:52 AM

GENEVA/ZURICH - Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial where the medicine failed, before giving it the green light, the top WHO scientist said on Friday. Read more »

Gilead's remdesivir gets US FDA approval for hospitalized COVID-19 patients

Deena Beasley, Reuters
Posted at Oct 23 05:58 AM

The US Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Read more »

Row breaks out over WHO trial casting doubt on remdesivir as COVID-19 drug

John Miller and Stephanie Nebehay, Reuters
Posted at Oct 17 05:39 AM

ZURICH/GENEVA - A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19. Read more »

Gilead's remdesivir shaved 5 days off COVID-19 recovery time, reduced risk of death in some

Julie Steenhuysen, Reuters
Posted at Oct 09 06:19 AM

CHICAGO - Final data from Gilead Sciences Inc's antiviral drug remdesivir showed the treatment cut COVID-19 recovery time by five days compared with patients who got a placebo, one day faster than indicated in preliminary data, the company and researchers said on Thursday. Read more »

Lilly's rheumatoid arthritis drug cuts COVID-19 deaths in trial, data shows

Reuters
Posted at Oct 09 03:15 AM

Lilly said the effect was most pronounced in patients on oxygen therapy, according to data from a US government-backed trial, which however, was not designed to measure the effectiveness of baricitinib in preventing death. Read more »

Gilead's remdesivir endorsed as first COVID-19 treatment in Europe

Reuters
Posted at Jun 25 08:57 PM

The European healthcare regulator has recommended the conditional approval of Gilead Sciences Inc's antiviral treatment, remdesivir, for use in COVID-19 patients, making it the first treatment to be on track to be green-lit in the continent. Read more »

Roche rheumatoid arthritis drug fails to help COVID-19 patients in Italian study

Emilio Parodi and Carl O'Donnell, Reuters
Posted at Jun 18 07:17 PM

Roche's rheumatoid arthritis drug Actemra failed to help patients with early-stage COVID-19 pneumonia in an Italian study, the latest instance in which an anti-inflammatory drug has fallen through in a coronavirus trial. Read more »

Singapore approves antiviral drug for COVID-19 patients

Agence France-Presse
Posted at Jun 10 05:13 PM

The city-state has the highest recorded number of infections in Southeast Asia with nearly 39,000 cases, mostly among foreign workers. Read more »

Gilead's remdesivir shows promise in COVID-19 study on monkeys

Reuters
Updated as of Jun 09 09:24 PM

Gilead Sciences Inc's antiviral drug, remdesivir, prevented lung disease in macaque monkeys infected with the new coronavirus, a study published in medical journal Nature showed on Tuesday. Read more »

S.Korea approves emergency use of Gilead's anti-viral drug to treat COVID-19

Reuters
Posted at Jun 03 12:43 PM

SEOUL - South Korea said on Wednesday it has approved the emergency use of Gilead Sciences Inc's remdesivir to treat COVID-19 after a government panel last week cited positive results for the anti-viral drug in other countries. Read more »

Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions

Deena Beasley, Reuters
Posted at Jun 03 01:08 AM

Gilead Sciences Inc is developing easier-to-administer versions of its antiviral treatment remdesivir for COVID-19 that could be used outside of hospitals, including ones that can be inhaled, after trials showed moderate effectiveness for the drug given by infusion. Read more »

Gilead says remdesivir helped moderate COVID-19 patients improve

Reuters
Posted at Jun 01 09:03 PM

Gilead Sciences Inc said on Monday results from a study showed its antiviral drug remdesivir demonstrated significantly greater clinical improvement in patients with moderate COVID-19. Read more »

Japan set to approve remdesivir for coronavirus treatment

Agence France-Presse
Posted at May 07 03:20 PM

TOKYO - Japan plans to authorize Thursday the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month. Read more »

COVID-19 patients respond positively to remdesivir in major US trial

Agence France-Presse
Updated as of Apr 30 12:29 AM

Gilead Science's remdesivir, one of the most highly anticipated drugs being tested against the new coronavirus, showed positive results in a large-scale US government trial, the company said Wednesday. Read more »

Experimental drug prevents type of coronavirus in monkeys; raises hope for China trials

Julie Steenhuysen, Reuters
Posted at Feb 14 09:42 AM

An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East Respiratory Syndrome (MERS), an infection closely related to the fast-spreading coronavirus that originated in China, a study published on Thursday found. Read more »